Discover 3,431 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,431
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
FeaturedActive & Responsive
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
for
Diabetic Foot Ulcer (DFU), Amnio-Maxx
Location: 8 recruiting locations
Sponsor: Royal Biologics
Sex: All
Age: 18+
Code: NCT07209475
Recruiting
Active & ResponsiveNew
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
for
Spasticity
Location: 3 recruiting locations
Sponsor: Ipsen
Sex: All
Age: 18 - 70
Code: NCT04752774
Phase1, Phase2, Recruiting
Active & ResponsiveNew
Acupuncture and Chinese Herbal Medicine for Long COVID
for
Long COVID
Location: 1 recruiting location
Sponsor: Southern California University of Health Sciences
Sex: All
Age: 18+
Code: NCT07285707
Recruiting
Active & Responsive
Fenofibrate for Prevention of DR Worsening
for
Diabetic Retinopathy
Location: 58 recruiting locations
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18 - 70+
Code: NCT04661358
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
for
Non-infected Venous Leg Ulcer, Venous Leg Ulcer,
Location: 18 recruiting locations
Sponsor: BioStem Technologies
Sex: All
Age: 18+
Code: NCT06811909
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
for
Primary IgA Nephropathy
Location: 36 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05797610
Phase3, Recruiting
Active & Responsive
A Study to Assess Pharmacokinetics, Safety, and Tolerability of Atumelnant in Healthy Japanese and Caucasian Participants
for
Healthy Volunteers
Location: 1 recruiting location
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 18 - 55
Code: NCT07221084
Phase1, Recruiting
Active & Responsive
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT